CLOBETASOL PROPIONATE
| Brand name | OLUX E |
|---|---|
| Active ingredient | CLOBETASOL PROPIONATE |
| Strength | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | AEROSOL, FOAM |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | January 2007 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8460641 | November 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.